Steve Strazza brings a unique perspective to the world of Technical Analysis due to his diverse background. Steve found an affinity for financial markets during his first job out of college as a big-4 CPA auditing some of Wall Street’s largest broker-dealers, such as Interactive Brokers and Morgan Stanley. Steve then worked in the Asset Management industry in a variety of roles including Controller for a private equity start-up, Fund Accountant at two large hedge funds, and most notably as a personal Accountant for Steve Cohen at SAC Capital and Point72. Steve has spent recent years writing as an Independent Research Analyst while working on a variety of Fintech projects for companies such as the TradeXchange and Deloitte & Touche. He also continues to practice part-time at his father’s CPA firm. Naturally, Steve began his research career using the financial statement analysis skills he gained as an accountant. After learning the flaws of fundamental analysis first-hand through his research career as well as his experience auditing public companies, he transitioned his investing style to focus primarily on price action. Steve holds an MBA from Fairfield University and is currently pursuing his CMT designation as a level 3 candidate.
For Wall Street veteran Jared Dillian, getting away from Wall Street might have been the best thing he ever did for himself.
Now living in South Carolina, he can’t be further removed from the lifestyle of your typical Wall Streeter. And he’d have it no other way, as he’s convinced Wall Street took at least 10 years off of his life expectancy.
As Jared says, his stress levels are now “basically zero.”
Milton Marmanides does the hard work that traders don’t have the time to do. He sifts through the firehose of headlines, news releases, data points, and social media to cut through the noise and deliver only the market-moving information active traders need to make smarter decisions.
And in his nearly 25 years in the business, first as a trader, and now as a market data provider, he’s seen a lot.
They are only losses if we don’t learn something from the experience.
When traders woke up on Monday, August 5th to the VIX at 65 and the Nasdaq index down 5% overnight, they didn’t need a cup of coffee to snap into high alert.
The easy first question to ask was: “What happened?”
Did you know there is a Chinese equivalent for all the top tech companies in the United States?
They do not import our technologies like most countries. They ban them. Then, they copy and recreate them with new names.
I love this clip from Silicon Valley, an old HBO show that poked fun at this. It was spot-on about a lot of things.
For purposes of this discussion, I ask you to forget any of your feelings on intellectual property theft and the general geopolitical concerns about Chinese technology. This has nothing to do with any of that.
This post is about making money on an emerging area of the international equities market.
There is a brand new bull market shaping up over in China. This is one of the largest and fastest-growing economies in the world. It is also home to some of the most innovative technology companies outside of America.
Thilo Schroeder, director of Revolution Medicines $RVMD and managing member of Nextech Invest, made waves with a $60 million insider buy, acquiring 1.3 million shares.
Nextech, known for investing in cutting-edge life sciences companies, often backs transformative players in oncology.
Schroeder's move underscores his confidence in RVMD’s potential.
Here’s The Hot Corner, with data from December 9, 2024:
